Articles

Emmanuel Matas, Alexandre Maisterrena, Mathieu Thabault, Eric Balado, Maureen Francheteau, et al.. Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model. Molecular Autism, BioMed Central, 2021, 12 (1), pp.2. ⟨10.1186/s13229-020-00412-8⟩. ⟨hal-03150112⟩

Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩. ⟨hal-02074093⟩

Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩. ⟨hal-03060272⟩

Sandra Holley, Laurie Galvan, Talia Kamdjou, Carlos Cepeda, Michael Levine. Striatal GABA ergic interneuron dysfunction in the Q175 mouse model of Huntington's disease. European Journal of Neuroscience, Wiley, 2018, ⟨10.1111/ejn.14283⟩. ⟨hal-02459725⟩

Lydie Boussicault, Sandro Alves, Antonin Lamazière, Anabelle Planques, Nicolas Heck, et al.. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 139 (3), pp.953-970. ⟨10.1093/brain/awv384⟩. ⟨hal-01299208⟩

Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩. ⟨hal-02459736⟩

Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩. ⟨hal-02459863⟩

Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoît Bernay, et al.. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo.. Neurobiology of Aging, Elsevier, 2015, pp.1601.e7-16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩. ⟨hal-01465910⟩

Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoit Bernay, et al.. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging, Elsevier, 2015, 36 (3), pp.1601.e7-1601.e16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩. ⟨hal-02459770⟩

Jamee m. Berg, Changhoon Lee, Leslie Chen, Laurie Galvan, Carlos Cepeda, et al.. JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron, Elsevier, 2015, 88 (6), pp.1173-1191. ⟨10.1016/j.neuron.2015.10.031⟩. ⟨hal-02459747⟩

Laetitia Francelle, Laurie Galvan, Emmanuel Brouillet. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Frontiers in Cellular Neuroscience, Frontiers, 2014, ⟨10.3389/fncel.2014.00295⟩. ⟨hal-02459873⟩

Jane Chen, Elizabeth Wang, Laurie Galvan, My Huynh, Prasad Joshi, et al.. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLoS Currents, Public Library of Science, 2013, ⟨10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202⟩. ⟨hal-02459786⟩

Maria Damiano, Elsa Diguet, Carole Malgorn, Marilena d'Aurelio, Laurie Galvan, et al.. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics, Oxford University Press (OUP), 2013, 22 (19), pp.3869-3882. ⟨10.1093/hmg/ddt242⟩. ⟨hal-02459752⟩

Laurie Galvan, Nad'A Lepejová, Marie-Claude Gaillard, Carole Malgorn, Martine Guillermier, et al.. Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging, Elsevier, 2012, 33 (8), pp.1845.e5-1845.e6. ⟨10.1016/j.neurobiolaging.2012.01.009⟩. ⟨hal-02459764⟩

Laurie Galvan, Elizabeth Wang, Carlos Cepeda, Michael Levine. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. Journal of Huntington's Disease, 2012, 1 (1), pp.17-25. ⟨10.3233/JHD-2012-120009⟩. ⟨hal-02459788⟩

Julie Espallergues, Laurie Galvan, Florence Sabatier, Vanessa Rana-Poussine, Tangui Tm Maurice, et al.. Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/−) mice showed no memory enhancement but hyposensitivity to amnesic drugs. Behavioural Brain Research, Elsevier, 2010, 206 (2), pp.263-273. ⟨10.1016/j.bbr.2009.09.024⟩. ⟨hal-02459760⟩

Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2010, 1802 (1), pp.52-61. ⟨10.1016/j.bbadis.2009.07.012⟩. ⟨hal-02459756⟩

Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2009, 1802 (1), pp.52. ⟨10.1016/j.bbadis.2009.07.012⟩. ⟨hal-00543005⟩

Julie Espallergues, Laurie Galvan, Laurence Lepourry, Béatrice Bonafos, Tangui Tm Maurice, et al.. Hyposensitivity to the amnesic effects of scopolamine or amyloid β25–35 peptide in heterozygous acetylcholinesterase knockout (AChE+/−) mice. Chemico-Biological Interactions, Elsevier, 2008, 175 (1-3), pp.131-134. ⟨10.1016/j.cbi.2008.04.001⟩. ⟨hal-02459753⟩